The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
DNA fingerprinting of the NCI-60 cell line panel
Open accessPublished version of a preprint
Abstract
The National Cancer Institute's NCI-60 cell line panel, the most extensively characterized set of cells in existence and a public resource, is frequently used as a screening tool for drug discovery. Because many laboratories around the world rely on data from the NCI-60 cells, confirmation of their genetic identities represents an essential step in validating results from them. Given the consequences of cell line contamination or misidentification, quality control measures should routinely include DNA fingerprinting. We have, therefore, used standard DNA microsatellite short tandem repeats to profile the NCI-60, and the resulting DNA fingerprints are provided here as a reference. Consistent with previous reports, the fingerprints suggest that several NCI-60 lines have common origins: the melanoma lines MDA-MB-435, MDA-N, and M14; the central nervous system lines U251 and SNB-19; the ovarian lines OVCAR-8 and OVCAR-8/ADR (also called NCI/ADR); and the prostate lines DU-145, DU-145 (ATCC), and RC0.1. Those lines also show that the ability to connect two fingerprints to the same origin is not affected by stable transfection or by the development of multidrug resistance. As expected, DNA fingerprints were not able to distinguish different tissues-of-origin. The fingerprints serve principally as a barcodes.[Mol Cancer Ther 2009;8(4):713–24]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some cell banks and laboratories now use a larger number, typically 16 loci.16,31”
From Match criteria for human cell line authentication: Where do we draw the line? (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell lines within these sets have previously been documented as having highly variable STR profiles, 7,16,28”
From Match criteria for human cell line authentication: Where do we draw the line? (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“STR loci are known to vary in the presence of microsatellite instability, with the degree of variability depending on the locus being assessed.16,28,43”
From Match criteria for human cell line authentication: Where do we draw the line? (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A variety of analytical approaches have indicated that melanoma cell line UCLA‐SO‐M14 (M14) and breast carcinoma cell line MDA‐MB‐435 originate from a common donor.”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“STR profiling of the NCI‐60 panel later confirmed the shared donor origin of these cells with M14.5”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620 · cited 2×
“Shoemaker RH.”
BackgroundIndividual-specific ‘fingerprints’ of human DNA
Jeffreys, A. J., Wilson, V., & Thein, S. L. (1985) · Nature · doi:10.1038/316076a0 · Cited by 2,150 · cited 1×
“DNA fingerprinting takes advantage of hypervariable regions within DNA (24).”
BackgroundSystematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088 · cited 1×
“However, we found on the basis of transcript expression profiles and other characteristics that they are melanomas (21, 22).”
BackgroundSelf-citationBoyd, M. R., & Paull, K. D. (1995) · Drug Development Research · doi:10.1002/ddr.430340203 · Cited by 1,572
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548 · cited 2×
“Resequencing (12) and genotyping (23) then showed the two to be direct relatives of the melanoma line M14.”
BackgroundA gene expression database for the molecular pharmacology of cancer
Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., et al. (2000) · Nature Genetics · doi:10.1038/73439 · Cited by 1,450 · cited 1×
“However, we found on the basis of transcript expression profiles and other characteristics that they are melanomas (21, 22).”
BackgroundSelf-citationGenetics and Genomics of Core Short Tandem Repeat Loci Used in Human Identity Testing
Butler, J. M. (2006) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2006.00046.x · Cited by 686 · cited 1×
“An inexpensive, standardized technique was developed for forensic and paternity applications based on short tandem repeat (STR) profiling of those hypervariable DNA regions (25), and it is now commonly employed for cell line characterization (26, 27).”
MethodShort tandem repeat profiling provides an international reference standard for human cell lines
Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478 · cited 7×
“An inexpensive, standardized technique was developed for forensic and paternity applications based on short tandem repeat (STR) profiling of those hypervariable DNA regions (25), and it is now commonly employed for cell line characterization (26, 27).”
BackgroundMethodResultInfluentialMutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ikediobi, O. N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 440 · cited 8×
“Likewise, SNB-19 was found (by resequencing) to be a direct relative of U251 (12).”
BackgroundSelf-citationYuan, Z. Q., Sun, M., Feldman, R. I., Wang, G., Ma, X.-L., Jiang, C., Coppola, D., Nicosia, S. V., & Cheng, J. Q. (2000) · Oncogene · doi:10.1038/sj.onc.1203598 · Cited by 384 · cited 1×
“A possible explanation for that extreme observation includes misidentification of an OVCAR-3 derivative selected for resistance to a particular treatment (31).”
Background
Cited by
Reinhold, W. C., Sunshine, M., Liu, H., Varma, S., Kohn, K. W., Morris, J., Doroshow, J., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1370 · Cited by 887
“3) and karyotypic analysis (4), (ii) DNA mutational analysis (5), (iii) DNA fingerprinting (6), (iv) microarrays for transcript expression (7–9), (v) microarrays for microRNA expression (9, 10), and (vi) protein reverse-phase lysate microarrays (11).”
BackgroundSelf-citationCheck your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520
“When searching an online database of STR profiles from cell lines, the user needs to look for close matches and not just identical matches; most studies would agree that 80% similarity is an appropriate threshold for declaring a match when comparing cell line profiles.(26,44) There may also be a significant start-up c…”
ResultHolbeck, S. L., Camalier, R., Crowell, J. A., Govindharajulu, J. P., Hollingshead, M., Anderson, L. W., Polley, E., Rubinstein, L., Srivastava, A., Wilsker, D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0489 · Cited by 359
“For each lot of cells, the Repository performed Applied Biosystems AmpFLSTR Identifiler testing with PCR amplification to confirm consistency with the published Identifiler STR profile (17) for the given cell line.”
MethodHolbeck, S. L., Collins, J. M., & Doroshow, J. H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0106 · Cited by 311
“More recently genotyping has been done with the AmpFlSTR Identifiler PCR Amplification kit (Applied Biosystems), with results consistent with published results from others (19).”
ResultGlobal Proteome Analysis of the NCI-60 Cell Line Panel
Gholami, A. M., Hahne, H., Wu, Z., Auer, F. J., Meng, C., Wilhelm, M., & Kuster, B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.018 · Cited by 302
Metadata
- Authors
- Lorenzi, P. L., Reinhold, W. C., Varma, S., Hutchinson, A. A., Pommier, Y., Chanock, S. J., & Weinstein, J. N.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- Molecular Cancer Therapeutics
- Published
- 2009-04-01
- Volume
- 8
- Issue
- 4
- Pages
- 713-724
- ISSN
- 1535-7163 (ISSN-L)
- 1538-8514
- PMC
- PMC4020356
- OpenAlex
- W1986694287
- Cited by
- 166
- References
- 32
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 14 · 2022: 6 · 2021: 14 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 6 · 2015: 12 · 2014: 15 · 2013: 16 · 2012: 20
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Cancer Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01co12400-79-0-22)
- National Cancer Institute (N01CO12400, N01-CO-012400, Z01BC007349)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic diversity and population structure
- Keywords
- NCI-60 cell lines, DNA fingerprinting, microsatellite markers, cell line misidentification, cell line contamination, melanoma cell lines, ovarian cancer cell lines, prostate cancer cell lines, multidrug resistance, stable transfection
- MeSH terms
- DNA, Neoplasm, Humans, Neoplasms, United States, Polymerase Chain Reaction, DNA Fingerprinting, Microsatellite Repeats, Cell Line, Tumor, National Cancer Institute (U.S.)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DNA fingerprinting of the NCI-60 cell line panel. https://app.cochat.ai/papers/10.1158/1535-7163.mct-08-0921
- The paper
- Lorenzi, P. L., Reinhold, W. C., Varma, S., Hutchinson, A. A., Pommier, Y., Chanock, S. J., & Weinstein, J. N. (2009). DNA fingerprinting of the NCI-60 cell line panel. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-08-0921
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.